Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paragh

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Ultrasound : JCU|February 19, 2000
Cerebrovascular reserve capacity in patients with hyperlipidemiaL L Kerenyi, B Fulesdi, A Ficzere, et al.
Orvosi Hetilap|July 20, 1997
[Lipid lowering treatment in secondary prevention following myocardial infarct]G Paragh, Z Balogh, J Boda, et al.
Diabetes & Metabolism|January 7, 2004
The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart diseaseG Paragh, I Seres, M Harangi, et al.
Orvosi Hetilap|October 15, 1995
[Cilazapril replacing captopril in the therapy of medium-severe essential hypertension]P Kovács, A Juhász, T Gábeli, et al.
Die Pharmazie|July 1, 2014
The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patientsN Zsíros, M Bodor, V Varga, et al.
Journal of Lipid Research|September 14, 1999
Altered signal pathway in granulocytes from patients with hypercholesterolemiaG Paragh, E Kovács, I Seres, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 1999
Disturbed LDL and scavenger receptor functions in monocytes from chronic haemodialysed patientsI Kárpáti, G Paragh, E Kovács, et al.
Nephron|September 16, 1998
The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemiaG Paragh, I Seres, Z Balogh, et al.
International Urology and Nephrology|February 11, 2000
The importance of bioimpedance (BIA) analysis and Cardio Tens (24-h ABPM and ECG) monitoring in the dialysis programmeL Löcsey, B Szlanka, I Ménes, et al.
Orvosi Hetilap|February 1, 2002
[Changes in lipid profile and paraoxonase activity in obese patients as a result of orlistat treatment]M Audikovszky, G Pados, I Seres, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Ultrasound : JCU|February 19, 2000
Cerebrovascular reserve capacity in patients with hyperlipidemiaL L Kerenyi, B Fulesdi, A Ficzere, et al.
Orvosi Hetilap|July 20, 1997
[Lipid lowering treatment in secondary prevention following myocardial infarct]G Paragh, Z Balogh, J Boda, et al.
Diabetes & Metabolism|January 7, 2004
The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart diseaseG Paragh, I Seres, M Harangi, et al.
Orvosi Hetilap|October 15, 1995
[Cilazapril replacing captopril in the therapy of medium-severe essential hypertension]P Kovács, A Juhász, T Gábeli, et al.
Die Pharmazie|July 1, 2014
The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patientsN Zsíros, M Bodor, V Varga, et al.
Journal of Lipid Research|September 14, 1999
Altered signal pathway in granulocytes from patients with hypercholesterolemiaG Paragh, E Kovács, I Seres, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 1999
Disturbed LDL and scavenger receptor functions in monocytes from chronic haemodialysed patientsI Kárpáti, G Paragh, E Kovács, et al.
Nephron|September 16, 1998
The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemiaG Paragh, I Seres, Z Balogh, et al.
International Urology and Nephrology|February 11, 2000
The importance of bioimpedance (BIA) analysis and Cardio Tens (24-h ABPM and ECG) monitoring in the dialysis programmeL Löcsey, B Szlanka, I Ménes, et al.
Orvosi Hetilap|February 1, 2002
[Changes in lipid profile and paraoxonase activity in obese patients as a result of orlistat treatment]M Audikovszky, G Pados, I Seres, et al.
Pageof 7